Success Metrics

Active Trials
4(44%)

Phase Distribution

Ph not_applicable
2
22%
Ph phase_2
5
56%
Ph phase_3
2
22%

Phase Distribution

0

Early Stage

5

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
5(55.6%)
Phase 3Large-scale testing
2(22.2%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

9

all time

Status Distribution
Active(8)
Other(1)

Detailed Status

Recruiting3
Not yet recruiting3
unknown1
Active, not recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
4
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 25 (55.6%)
Phase 32 (22.2%)
N/A2 (22.2%)

Trials by Status

recruiting333%
not_yet_recruiting333%
unknown111%
active_not_recruiting111%
enrolling_by_invitation111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9